From University Project to Startup

Particle3D is a spinout medico company from the University of Southern Denmark and is founded by Casper Slots, Martin Bonde Jensen, and Morten Østergaard Andersen.

In 2014, a new biomaterials research unit at the university, established by Associate Professor, Morten Østergaard Andersen, with the goal of developing clinically implementable solutions to real medical problems defined by clinicians.

This business idea came about as a result of working 12 years with bone tissue engineering and seeing unrealistic solutions being promoted for clinical non-problems while real clinical problems remained unsolved. 

The two then medical engineering students, Martin Bonde Jensen and Casper Slots, were recruited to work on this project in the newly established biomaterials laboratory ― and this was when the three founders first started working together.

The then head of the unit for Oral and Maxillofacial Surgery at Odense University Hospital asked them to investigate an implant solution for replacing destroyed or surgically removed bone that could surpass all conventional treatments offered. He requested a material that is easily moldable, slowly degradable, and natural to the human body ― allowing surgeons to restore the patient’s tissue to its former shape and composition.

This project resulted in the invention of a unique bio-ink that could be 3D printed into personalized and resorbable implants for human use, and in 2015, a patent application was filed for this innovative technology.


Founding of the Medico Company

The Company was subsequently founded in August, 2017, after Particle3D won the Danish Venture Cup ― a national startup competition that came with a prize of USD 16,000 and a trip to Silicon Valley.

Since then, Particle3D has received several awards for developing the technology, including the Best Nordic Health Tech Startup in the Nordic Startup Awards 2020, and grants from Novo Nordisk and InnoBooster. In 2020, Particle3D was recognized as one of the Top 5 emerging biofabrication startups impacting the global BioTech industry by StartUs Insights

Particle3D raised its first seed funding in 2018 of USD 775,000 from PreSeed Ventures and private investors and a Series A funding in 2020 of USD 3.5 million from West Hill Capital.

Today, the Company is working to make bone replacements more accurate, effective, and safe. With a mission to provide novel bone implants that are more natural in terms of material, shape, and structure, Particle3D is aiming to reduce complications, improve functional and aesthetic outcomes, and obtain faster recovery.

In short: We Print Bone™

More from our Blog and Newsroom

Ossiform – Announces rebrand

Ossiform – Announces rebrand

Ossiform - Announces rebrand ODENSE, January 5th, 2022 – Ossiform, We Print Bone™, is pleased to announce that it has completed its rebranding. With the approaching launch of its first bone implant for human use, the Company has rapidly grown and matured, and the...

Patent for Particle3D’s technology granted in China

Patent for Particle3D’s technology granted in China

Chinese Patent Granted for Particle3D's 3D printing technology August 10th 2021, the China National Intellectual Property Administration (CNIPA) announced that Particle3D's patent, Feedstock for 3D printing and uses thereof no. PCT/DK2016/050323, has been granted in...

What 3D printing is all about

What 3D printing is all about

3D printing may sound like something from a galaxy far, far away, but the technology has been around for quite some time. Throughout the years, scientists from all over the world have printed everything; from small food items to large scale houses, and in the medical...